MedPath

Cytisine as a smoking cessation aid: measuring blood levels, craving, withdrawal and mood over a course of treatment

Phase 1
Completed
Conditions
Smoking
Other - Conditions of unknown or disputed aetiology (such as chronic fatigue syndrome/myalgic encephalomyelitis)
Registration Number
ACTRN12613000002785
Lead Sponsor
niversity of Auckland
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
12
Inclusion Criteria

Smokers
They will be eligible for inclusion in the trial if:
- they are at least 18 years of age,
- they are able to provide written consent,
- willing to attempt to quit smoking
- are currently a regular smoker.

Exclusion Criteria

-pregnant or breastfeeding,
-current users of NRT products,
-current users of non-NRT smoking cessation therapies (e.g. buproprion [registered tradename Zyban], clonidine, nortriptyline, or varenicline [registered tradename Champix]),
-enrolled in another smoking cessation programme
-have had a heart attack, stroke, or severe angina within the previous two weeks,
-have uncontrolled high blood pressure (> 150 mmHg systolic, > 100 mmHg diastolic),
-have phaeochromocytoma,
-suffer from schizophrenia.
-have severe renal impairment
-have had an adverse reaction to varenicline or cytisine

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Cytisine plasma levels measured by blood samples [just before the first dose, then 2, 4, 6, 8, 10, 24 hours and then in the morning on days 2, 3, 4, 5, 6, 13, 14, 17, 18, 21, 22, 25 (plus again after 2, 4, and 6 hours), and day 26. ]
Secondary Outcome Measures
NameTimeMethod
Cotinine levels in saliva using Nicalert sticks.[days 1,2,3,4,5,6,13,14,17,18,21,22,25 ];vital signs - electronic blood pressure and pulse monitor[just before the first dose, then 2, 4, 6, 8, 10, 24 hours and then in the morning on days 2, 3, 4, 5, 6, 13, 14, 17, 18, 21, 22, 25 (plus again after 2, 4, and 6 hours), and day 26. ];craving for cigarettes (Brief Questionnaire on Smoking Urges1)[days 1,2,3,4,5,6,13,14,17,18,21,22,25, 26 ];withdrawal (Mood and Physical Symptoms Score (MPSS), and the modified Cigarette Evaluation Questionnaire),[days 1,2,3,4,5,6,13,14,17,18,21,22,25, 26];mood (Profile of Mood States (POMS))[days 1,2,3,4,5,6,13,14,17,18,21,22,25, 26];metabolites in urine[urine samples on days 1,2,3,4,5,6,13,14,17,18,21,22,25, 26]
© Copyright 2025. All Rights Reserved by MedPath